Therapy of gastric lymphoma of MALT type, including antibiotics
This chapter addresses the systemic therapy of marginal B cell lymphoma, a category which comprises MALT-type lymphomas and monocytoid B cell lymphomas [20. 1]. These two different subtypes are approximately equal in frequency,1 but this chapter restricts its scope to lymphomas of the stomach.
KeywordsMalt Lymphoma Marginal Zone Lymphoma Gastric Lymphoma Gastric Malt Lymphoma Marginal Zone BCell Lymphoma
Unable to display preview. Download preview PDF.
- 1.Fisher RI, Dahlberg S, Nathwani BN, Banks PIVI, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995; 85:1075–82.PubMedGoogle Scholar
- 13.Fisher RI. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma. Important Adv Oncol 1990; 217–25.Google Scholar
- del Valle F, Hiddemann W, Willich N et al. (for the German Multicenter Study Group on GI-NHL). Clinical presentation of 371 primary gastrointestinal lymphoma: Results of a prospective multicenter study. Blood 1997; 90 (Suppl 1), 338a (abstract 1507).Google Scholar
- Koch P, del Valle F, Hiddemann W et al. (for the German Multicenter Study Group on GI-NHL). Primary gastrointestinal (GI) lymphoma in 371 patients: Data from a prospective multicentre study. Blood 1997; 90 (Suppl 1): 586a (abstract 2608).Google Scholar